Financials

News Ideas Minds

10B fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to BIOSERVO TECHNOLAB operating, investing, and financing activities

10B free cash flow for Q3 23 is -1.31 M EUR. For 2022, 10B free cash flow was -4.6 M EUR and operating cash flow was -4.51 M EUR.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—